Alvion

Alvion Pharmaceuticals is a research-driven B2B pharmaceutical company based in Greece, specializing in the development, manufacturing, and out-licensing of generic and value-added medicines. The company focuses on complex pharmaceutical products and difficult-to-make formulations across therapeutic areas such as oncology, cardiovascular, and the central nervous system. Alvion provides a comprehensive suite of services including R&D, intellectual property strategy, and regulatory support to its global network of partners. With a portfolio of over 50 products, the company maintains a significant presence in European and international markets, emphasizing high-quality standards and cost-effective healthcare solutions. Their business model centers on 'Day 1' generic launches and the development of hybrid medicines that offer improved patient outcomes.